Balanced news tone
News Sentiment
ELOX sentiment intelligence
Eloxx Pharmaceuticals, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
34 relevant articles
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-6.0% over one week, -12.6% over four weeks, trend inactive, and near fair-value range.
Price to book forward of Eloxx Pharmaceuticals, Inc. – NASDAQ:ELOX
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
82/100 classification
One-week reaction
-6.0%
Price reacting lower
Trend fit
Trend inactive
-12.6% over four weeks
Fair value
-7.6%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
29
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
Price to book forward of Eloxx Pharmaceuticals, Inc. – NASDAQ:ELOX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 15:47
- Source
- TradingView
ad-hoc-news.de
Direct company coverage
ELOX stock trades on Nasdaq as small-cap biotech focuses on cystic fibrosis therapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 15:48
- Source
- ad-hoc-news.de
TradingKey
Direct company coverage
ELOX|Eloxx Pharmaceuticals Ord Shs|Price:12.270|Chg%:+1.320
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 13:22
- Source
- TradingKey
Benzinga España
Direct company coverage
Eloxx Pharma (ELOX) Stock Analysis Report | Financials & Insights
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Benzinga España
TradingView
Direct company coverage
Why Tenet Healthcare (THC) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 15:31
- Source
- TradingView
Finviz
Direct company coverage
ELOX - Eloxx Pharmaceuticals Inc Latest SEC Filings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 19:11
- Source
- Finviz
TradingKey
Direct company coverage
Eloxx Pharmaceuticals Ord Shs (ELOX) Shareholder Structure: Major Shareholders & Institutional Holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 09:27
- Source
- TradingKey
TradingKey
Direct company coverage
Eloxx Pharmaceuticals Ord Shs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 08:51
- Source
- TradingKey
TradingKey
Direct company coverage
Eloxx Pharmaceuticals Ord Shs (ELOX) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 08:28
- Source
- TradingKey
Stock Titan
Direct company coverage
Coastlands (NASDAQ: ELOX) discloses 410,530 shares, 9.99% stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Domicilium group discloses 19.99% stake in Eloxx (NASDAQ: ELOX)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Stonepine-affiliated holders report 403,228 shares in Eloxx (ELOX) — 9.9% stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
CNN
Direct company coverage
symbol__ Stock Quote Price and Forecast
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 10 Jun 2026 18:53
- Source
- CNN
Stock Titan
Direct company coverage
Eloxx (ELOX) director Stephen Webster receives stock options for 13,587 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Stock Titan
Morningstar
Direct company coverage
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- Morningstar
The Globe and Mail
Direct company coverage
Eloxx Pharmaceuticals Executes Reverse Stock Split and Governance Revamp
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- The Globe and Mail
Stock Titan
Direct company coverage
Eloxx Pharmaceuticals (ELOX) lines up stock and pre-funded warrant raise tied to Nasdaq listing
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Quiver Quantitative
Direct company coverage
PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Quiver Quantitative
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Investopedia
Direct company coverage
UnitedHealth Group Stock Soars on Strong Earnings, Boosted Outlook
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Investopedia
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Investopedia
Direct company coverage
How Much Is UnitedHealth Group Stock Expected to Move After Earnings?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Apr 2026 07:00
- Source
- Investopedia
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Kavout | AI
Direct company coverage
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Feb 2026 09:53
- Source
- Kavout | AI
TIKR.com
Direct company coverage
Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Feb 2026 08:00
- Source
- TIKR.com